263 related articles for article (PubMed ID: 33902190)
1. [Analysis of bone mineral density and its influencing factors in 211 patients with chronic hepatitis B treated with long-term entecavir monotherapy].
Ning HB; Jin HM; Li K; Peng Z; Li W; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):234-239. PubMed ID: 33902190
[No Abstract] [Full Text] [Related]
2. Effects of Long-Term Tenofovir and Entecavir Treatment on Bone Mineral Density in Patients with Chronic Hepatitis B.
Kahraman R; Şahin A; Öztürk O; Çalhan T; Sayar S; Kanat E; Doğanay L; Özdil K
Turk J Gastroenterol; 2022 Jan; 33(1):35-43. PubMed ID: 35040786
[TBL] [Abstract][Full Text] [Related]
3. Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial.
Lim YS; Gwak GY; Choi J; Lee YS; Byun KS; Kim YJ; Yoo BC; Kwon SY; Lee HC
J Hepatol; 2019 Jul; 71(1):35-44. PubMed ID: 30876946
[TBL] [Abstract][Full Text] [Related]
4. Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir.
Tonon M; Piano S; Romano A; Fasolato S; Stanco M; Pilutti C; Pontisso P; Mareso S; Gambino C; Sartori L; Angeli P
Eur J Gastroenterol Hepatol; 2018 Mar; 30(3):284-290. PubMed ID: 29309397
[TBL] [Abstract][Full Text] [Related]
5. Bone loss in hepatitis B virus-infected patients can be associated with greater osteoclastic activity independently of the retroviral use.
Dessordi R; Watanabe LM; Guimarães MP; Romão EA; de Lourdes Candolo Martinelli A; de Carvalho Santana R; Navarro AM
Sci Rep; 2021 May; 11(1):10162. PubMed ID: 33986322
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.
Alcalde Vargas A; Pascasio Acevedo JM; Gutiérrez Domingo I; García Jiménez R; Sousa Martín JM; Ferrer Ríos MT; Sayago Mota M; Giráldez Gallego A; Gómez Bravo MA
Transplant Proc; 2012; 44(6):1496-8. PubMed ID: 22841194
[TBL] [Abstract][Full Text] [Related]
7. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal study on physical fitness parameters influencing bone mineral density reduction in middle-aged and elderly women: bone mineral density in the lumbar spine, femoral neck, and femur.
Iida T; Ikeda H; Shiokawa M; Aoi S; Ishizaki F; Harada T; Ono Y
Hiroshima J Med Sci; 2012 Jun; 61(2):23-8. PubMed ID: 22916509
[TBL] [Abstract][Full Text] [Related]
9. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
Ghannam NN; Hammami MM; Bakheet SM; Khan BA
Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
Al-Shoumer KA; Nair V
Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of Entecavir monotherapy switched from Lamivudine combined Adefovir Dipivoxil for chronic hepatitis B virus-related compensated liver cirrhosis].
Lai XJ; Lian JS; Chen JY; Zhang YM; Jia HY; Zheng L; Yang YD
Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):113-118. PubMed ID: 29804377
[No Abstract] [Full Text] [Related]
13. Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?
Gur A; Dikici B; Nas K; Bosnak M; Haspolat K; Sarac AJ
BMC Gastroenterol; 2005 Sep; 5():30. PubMed ID: 16171525
[TBL] [Abstract][Full Text] [Related]
14. Associations between objectively-measured sedentary behaviour and physical activity with bone mineral density in adults and older adults, the NHANES study.
Chastin SF; Mandrichenko O; Helbostadt JL; Skelton DA
Bone; 2014 Jul; 64():254-62. PubMed ID: 24735973
[TBL] [Abstract][Full Text] [Related]
15. [Changes in serum β2-microglobulin, retinol-binding protein, and cystatin C and their value in identifying early renal dysfunction in patients with chronic hepatitis B undergoing tenofovir or entecavir monotherapy: a comparative analysis].
He J; Ning HB; Zeng YL; Li W; Li K; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):643-646. PubMed ID: 27788718
[No Abstract] [Full Text] [Related]
16. Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008-2010 Korea National Health and Nutrition Examination Surveys.
Baeg MK; Yoon SK; Ko SH; Han KD; Choi HJ; Bae SH; Choi JY; Choi MG
Hepatol Int; 2016 May; 10(3):470-7. PubMed ID: 26850597
[TBL] [Abstract][Full Text] [Related]
17. Aged-Related Changes in Body Composition and Association between Body Composition with Bone Mass Density by Body Mass Index in Chinese Han Men over 50-year-old.
Jiang Y; Zhang Y; Jin M; Gu Z; Pei Y; Meng P
PLoS One; 2015; 10(6):e0130400. PubMed ID: 26090818
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir.
Choi HN; Song JE; Lee HC; Jo HH; Lee CH; Kim BS
Clin Mol Hepatol; 2015 Mar; 21(1):24-31. PubMed ID: 25834799
[TBL] [Abstract][Full Text] [Related]
19. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.
Wang JL; Du XF; Chen SL; Yu YQ; Wang J; Hu XQ; Shao LY; Chen JZ; Weng XH; Zhang WH
World J Gastroenterol; 2015 Aug; 21(32):9598-606. PubMed ID: 26327767
[TBL] [Abstract][Full Text] [Related]
20. BMI and gender increase risk of sacral fractures after multilevel instrumented spinal fusion compared with bone mineral density and pelvic parameters.
Salzmann SN; Ortiz Miller C; Carrino JA; Yang J; Shue J; Sama AA; Cammisa FP; Girardi FP; Hughes AP
Spine J; 2019 Feb; 19(2):238-245. PubMed ID: 29792998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
